Cna Financial Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$29.63 - $48.31 $58,371 - $95,170	-1,970 Reduced 15.07%	11,100 $367,000
Q2 2022 Aug 09, 2022	SELL	$27.79 - $50.61 $14,450 - $26,317	-520 Reduced 3.83%	13,070 $460,000
Q1 2022 May 10, 2022	BUY	$39.62 - $69.97 $34,073 - $60,174	860 Added 6.76%	13,590 $625,000
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $739,485 - $1.05 Million	12,730 New	12,730 $844,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.